Kenichi Samejima

6PUBLICATIONS
14CO-AUTHORS
Biologically active moleculesMolecular medicineNutritional epidemiologyCardiology (incl. cardiovascular diseases)Nutrigenomics and personalised nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 19, 2025
Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Lower eGFR Decline in Nondiabetic CKD Patients without Proteinuria.

Masaru Matsui, Takaaki Kosugi, Kosuke Tansho

|Feb 16, 2022
Correction to: Association of initial prednisolone dose with remission, relapse, and infectious complications in adult‑onset minimal change disease.

Kaori Tanabe, Ken-Ichi Samejima, Fumihiro Fukata

|Aug 08, 2021
Association of initial prednisolone dose with remission, relapse, and infectious complications in adult-onset minimal change disease.

Kaori Tanabe, Ken-Ichi Samejima, Fumihiro Fukata

|Nov 05, 2020
Microscopic hematuria is a risk factor for end-stage kidney disease in patients with biopsy-proven diabetic nephropathy.

Sadanori Okada, Ken-Ichi Samejima, Masaru Matsui

|Apr 11, 2020
Renal arteriolar hyalinosis, not intimal thickening in large arteries, is associated with cardiovascular events in people with biopsy-proven diabetic nephropathy.

K Morimoto, M Matsui, K Samejima

|Mar 06, 2019
Nonproteinuric Versus Proteinuric Phenotypes in Diabetic Kidney Disease: A Propensity Score-Matched Analysis of a Nationwide, Biopsy-Based Cohort Study.

Masayuki Yamanouchi, Kengo Furuichi, Junichi Hoshino

Pageof 1

Frequent Collaborators

1 joint publications

Masaru Matsui

1 joint publications

Takaaki Kosugi

1 joint publications

Kosuke Tansho

1 joint publications

Shunsuke Kitamura